I think they have invested quite a bit in Marketing to push the brands out there and get those sales,
Now it remains to be seen if they can keep the sales and margins, whilst reducing those operating costs.
The full financial reports will be interesting to see.
- Forums
- ASX - By Stock
- GDA
- Ann: FY22 Results
Ann: FY22 Results, page-5
-
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GDA (ASX) to my watchlist
(20min delay)
|
|||||
Last
26.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.01M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3813 | 27.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
27.5¢ | 600 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3813 | 0.270 |
3 | 29600 | 0.265 |
7 | 139570 | 0.260 |
2 | 100021 | 0.255 |
2 | 14223 | 0.250 |
Price($) | Vol. | No. |
---|---|---|
0.275 | 600 | 1 |
0.285 | 7382 | 2 |
0.290 | 22375 | 2 |
0.300 | 7941 | 1 |
0.310 | 5481 | 2 |
Last trade - 11.34am 11/10/2024 (20 minute delay) ? |
Featured News
GDA (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online